Curis, Inc.
CRISNASDAQHealthcare● Active
$0.47
+$0.00(+0.28%)
Market Cap$6208410
P/E Ratio—
52W High$3.13
52W Low$0.46
Curis, Inc. (CRIS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CRIS · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$1.25
Est. -$0.29 · -331.0%
Revenue
—
Est. $0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▼ Miss EPS
CRIS reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$93.32
Rev. $1001.5B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$93.32
Rev. Est.$1001.5B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | -$0.35 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 12, 2026 | -$0.29 | -$1.25 | -331.0% | — | $0.00B | — |
| ▼ Q1 FY2026 | Mar 19, 2026 | -$0.44 | -$0.50 | -14.7% | $0.00B | $0.00B | -65.0% |
| ▲ Q4 FY2025 | Nov 6, 2025 | -$0.62 | -$0.49 | +21.0% | $0.00B | $0.00B | +11.1% |
| ▲ Q3 FY2025 | Aug 5, 2025 | -$1.99 | -$0.68 | +65.8% | $0.00B | $0.00B | -3.9% |
| ▼ Q2 FY2025 | May 6, 2025 | -$1.14 | -$1.25 | -9.7% | $0.00B | $0.00B | -20.7% |
| ▲ Q1 FY2025 | Mar 31, 2025 | -$1.36 | -$1.25 | +8.1% | $0.00B | $0.00B | +60.0% |
| ▲ Q4 FY2024 | Nov 14, 2024 | -$1.88 | -$1.70 | +9.6% | $0.00B | $0.00B | +23.7% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
-$0.35
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Miss
EPS Actual
-$1.25
EPS Est.
-$0.29
EPS Surpr.
-331.0%
Revenue
—
Q1 FY2026
Mar 19, 2026Miss
EPS Actual
-$0.50
EPS Est.
-$0.44
EPS Surpr.
-14.7%
Revenue
$0.00B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
-$0.49
EPS Est.
-$0.62
EPS Surpr.
+21.0%
Revenue
$0.00B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
-$0.68
EPS Est.
-$1.99
EPS Surpr.
+65.8%
Revenue
$0.00B
Q2 FY2025
May 6, 2025Miss
EPS Actual
-$1.25
EPS Est.
-$1.14
EPS Surpr.
-9.7%
Revenue
$0.00B
Q1 FY2025
Mar 31, 2025Beat
EPS Actual
-$1.25
EPS Est.
-$1.36
EPS Surpr.
+8.1%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024Beat
EPS Actual
-$1.70
EPS Est.
-$1.88
EPS Surpr.
+9.6%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.10 | $-0.10 | $-0.10 | 1 |
| Q3 FY2026 | $-0.40 | $-0.40 | $-0.40 | 2 |
| Q2 FY2026 | $-0.41 | $-0.41 | $-0.41 | 2 |
| Q1 FY2026 | $-0.33 | $-0.33 | $-0.33 | 1 |
| Q4 FY2025 | $-0.53 | $-0.44 | $-0.33 | 3 |
| Q3 FY2025 | $-0.69 | $-0.58 | $-0.46 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 12, 2026 | -331.0% | $0.55 | $0.55 | -0.11% |
| ▼ Q1 FY2026 | Mar 19, 2026 | -14.7% | $0.82 | $0.76 | -7.14% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +21.0% | $1.42 | $1.46 | +2.82% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +65.8% | $1.60 | $1.67 | +4.37% |
| ▼ Q2 FY2025 | May 6, 2025 | -9.7% | $2.45 | $2.19 | -10.61% |
| ▲ Q1 FY2025 | Mar 31, 2025 | +8.1% | $2.32 | $2.10 | -9.48% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +9.6% | $3.93 | $3.98 | +1.27% |
| ▼ Q3 FY2024 | Aug 1, 2024 | -19.4% | $5.48 | $4.94 | -9.85% |
Q2 FY2026-0.11%
Report Date
May 12, 2026
EPS Beat/Miss
-331.0%
Price Before
$0.55
Price After
$0.55
Q1 FY2026-7.14%
Report Date
Mar 19, 2026
EPS Beat/Miss
-14.7%
Price Before
$0.82
Price After
$0.76
Q4 FY2025+2.82%
Report Date
Nov 6, 2025
EPS Beat/Miss
+21.0%
Price Before
$1.42
Price After
$1.46
Q3 FY2025+4.37%
Report Date
Aug 5, 2025
EPS Beat/Miss
+65.8%
Price Before
$1.60
Price After
$1.67
Q2 FY2025-10.61%
Report Date
May 6, 2025
EPS Beat/Miss
-9.7%
Price Before
$2.45
Price After
$2.19
Q1 FY2025-9.48%
Report Date
Mar 31, 2025
EPS Beat/Miss
+8.1%
Price Before
$2.32
Price After
$2.10
Q4 FY2024+1.27%
Report Date
Nov 14, 2024
EPS Beat/Miss
+9.6%
Price Before
$3.93
Price After
$3.98
Q3 FY2024-9.85%
Report Date
Aug 1, 2024
EPS Beat/Miss
-19.4%
Price Before
$5.48
Price After
$4.94
Avg Beat Reaction-0.26%
Avg Miss Reaction-6.93%
Beat Rate4 / 8 quarters
Largest Move-10.61% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CRIS ends December
Curis, Inc. (CRIS) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-1.25 — missing the analyst consensus of $-0.29 by -331.0%. The next CRIS earnings date is expected around September 1, 2026.
Each quarter, investors track CRIS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CRIS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CRIS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CRIS earnings · 5 questionsCuris, Inc.'s next earnings report is expected around September 1, 2026. CRIS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CRIS historically reports after market close (AMC).
CRIS earnings datewhen is CRIS earningsCRIS next earnings datewhen does CRIS report earningsCRIS earnings calendar
▸ Source: FMP · Curis, Inc. SEC filings · US GAAP · Curis, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026